Softgel Encapsulation Machine Market

Softgel Encapsulation Machine Market Analysis and Forecast by Fact.MR

• The global softgel encapsulation machine market covers specialized pharmaceutical manufacturing equipment used to produce soft gelatin capsules for pharmaceutical, nutraceutical, cosmetic, and veterinary applications.
• The category includes rotary die encapsulation machines, plate-type machines, die roller systems, fully automatic machines, and semi-automatic machines.
• These systems use encapsulation, gelatin processing, automation, and filling technologies to produce softgels with precise fill weights, uniform shell thickness, and consistent quality.
• Demand is shaped by pharmaceutical production volumes, dietary supplement market growth, contract manufacturing expansion, cosmetic softgel adoption, and the growing requirement for high-speed, automated encapsulation lines.

Summary of the Softgel Encapsulation Machine Market

• Market Snapshot
  • In 2025, the global Softgel Encapsulation Machine Market was valued at approximately USD 720.0 million.
  • The market is estimated to reach USD 756.7 million in 2026 and is projected to attain USD 1244.4 million by 2036.
  • The softgel encapsulation machine market is likely to expand at a CAGR of 5.1% during the forecast period.
  • The market is anticipated to create an absolute dollar opportunity of USD 487.7 million between 2026 and 2036.
  • Rotary Die Softgel Encapsulation Machines accounts for 46% of product share in 2026.
  • India (7%) and China (6%) are the key growth markets during the forecast period.
• Demand and Growth Drivers
  • The growing pharmaceutical manufacturing and the rising preference for softgel formulations in drug delivery contribute to the highest demand for softgel encapsulation machines, resulting in the increased procurement of equipment.
  • The demand for encapsulation equipment is sustained by the growth in the dietary supplement market as nutraceutical companies are expanding their production capacity for vitamins, omega fatty acids and herbal supplements.
  • The growth of contract manufacturing organizations is driving investment in high-speed, multi-product encapsulation lines for a range of pharmaceutical and supplement clients.
  • The increasing use of cosmetic softgels for skin care, hair care and beauty supplements is leading to growing demand for new production capacity in addition to existing pharmaceutical and supplement applications.
  • Automation and the need for high-speed production are driving the increased demand for upgrades, as manufacturers trade semi-automatic lines for fully automated encapsulation systems.
• Product and Segment View
  • Rotary Die Softgel Encapsulation Machines are projected to capture 46% share of the product segment in 2026 owing to wider applicability and established installed base across core end-use verticals.
  • The pharmaceutical industry held the largest application segment of 58% in 2026 owing to institutional procurement, regulatory requirements and increasing professional adoption.
  • Encapsulation Technology leads the technology segment with 66% of the segment. This is because Encapsulation Technology is the standard operational technology.
  • Key segmentation includes:
    • Product: Rotary Die Softgel Encapsulation Machines, Plate Type Encapsulation Machines, Die Roller Systems, Fully Automatic Machines, Semi Automatic Machines
    • Application: Pharmaceutical Industry, Dietary Supplements, Cosmetic Industry, Veterinary Applications
    • Distribution Channel: Direct Sales, Distributors, Contract Sales, Aftermarket Services
  • These systems enable:
    • Measurement, monitoring, or control functions across distributed operational environments.
    • Remote management and data integration through connected platforms.
    • Performance optimization in applications where precision and reliability are primary procurement criteria.
• Geography and Competitive Outlook
  • North America shows stable demand supported by established end-use verticals, replacement cycles, and technology upgrade activity.
  • Europe is experiencing steady growth from regulatory compliance, process modernization, and expanding professional adoption.
  • Asia Pacific is the fastest-growing region, with India (7%) and China (6%) leading demand expansion.
  • Key companies include IMA Group, Bosch Packaging, Harro Höfliger, ACG, Romaco, and Fette Compacting, Marchesini, SaintyCo.
• Analyst Opinion
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, says 'The softgel encapsulation machine market is shaped by pharmaceutical production volumes, supplement industry growth, and the shift toward high-speed automated lines. Rotary die machines lead because they offer the highest production speed, most consistent capsule quality, and greatest flexibility for different fill formulations across pharmaceutical and supplement manufacturing. Pharmaceutical industry accounts for the largest application share because prescription and OTC softgel drug products generate the highest quality requirements and largest production volumes per machine. India and China are the fastest-growing markets because pharmaceutical manufacturing expansion, domestic supplement production, and contract manufacturing growth are generating new encapsulation line procurement. The competitive differentiation is machine speed, fill accuracy, and changeover flexibility, which determine production economics for manufacturers running multiple products on shared equipment.'

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• Pharmaceutical production expansion is generating the largest procurement volume for encapsulation machines as softgel drug delivery gains market share across therapeutic categories.
• Dietary supplement industry growth is driving capacity investment in encapsulation equipment for vitamins, omega fatty acids, probiotics, and herbal supplement production.
• Contract manufacturing expansion is creating demand for high-speed, multi-product encapsulation lines capable of serving multiple pharmaceutical and supplement clients.

Key Market Constraints

• High machine cost limits procurement to established pharmaceutical and supplement manufacturers with sufficient production volume to justify capital investment.
• Regulatory validation requirements for pharmaceutical-grade encapsulation equipment add lead time and cost to machine commissioning and qualification.
• Gelatin supply constraints and the transition toward plant-based capsule materials create formulation challenges that require machine adaptation.

Key Opportunity Areas

• Plant-based and vegan softgel encapsulation technology is creating demand for machines capable of processing non-gelatin shell materials with different processing characteristics.
• High-speed encapsulation lines with integrated quality inspection, weight checking, and reject systems are commanding premium pricing through production efficiency gains.
• Emerging market pharmaceutical manufacturing investment is generating new machine procurement as countries build domestic drug and supplement production capability.

Segment-wise Analysis of the Softgel Encapsulation Machine Market

• Rotary Die Softgel Encapsulation Machines hold 46% of the product segment in 2026, supported by their broad applicability, lower complexity, and continued use across the largest end-use verticals.
• Pharmaceutical Industry represents 58% of the application segment in 2026, with institutional demand, regulatory mandates, and professional adoption acting as the primary demand channels.
• Encapsulation Technology accounts for 66% of the technology segment, reflecting its established operational role and broad installed base.

The softgel encapsulation machine market is segmented by product, application, end use, technology, formulation, distribution channel, and region. By product, the market covers Rotary Die Softgel Encapsulation Machines, Plate Type Encapsulation Machines, Die Roller Systems, Fully Automatic Machines, Semi Automatic Machines. By application, coverage includes Pharmaceutical Industry, Dietary Supplements, Cosmetic Industry, Veterinary Applications. Rotary Die Softgel Encapsulation Machines leads by value in the near term because of their installed base and broad applicability, while emerging segments are expected to drive the next phase of growth as requirements evolve.

Which Product Segment Dominates the Softgel Encapsulation Machine Market?

Rotary die softgel encapsulation machines are expected to account for 46.0% of the product type segment in 2026. Their leadership reflects the superior production speed, capsule consistency, and formulation flexibility that make rotary die systems the standard for high-volume pharmaceutical and supplement manufacturing. Plate-type encapsulation machines hold the second-largest share, with demand driven by smaller-scale production, R&D applications, and contract manufacturers requiring flexible, lower-throughput encapsulation capability.

Which Application Segment Dominates the Softgel Encapsulation Machine Market?

Pharmaceutical industry is expected to account for 58.0% of the application segment in 2026. This dominance reflects the scale of pharmaceutical softgel production, where prescription and OTC drug products generate the highest quality requirements and largest per-machine production volumes. Dietary supplements represent the second-largest application, with demand shaped by the growing consumer market for vitamins, omega fatty acids, herbal supplements, and beauty nutrition products in softgel format.

Which Product Trend is Shaping the Next Phase of Growth in the Softgel Encapsulation Machine Market?

The fastest growing segment is fully automated encapsulation lines with integrated inspection and plant-based capsule capability, though not yet the standard configuration. As pharmaceutical and supplement manufacturers look to increase throughput, improve quality control and have the ability to produce both gelatin and non-gelatin softgels on the same line, their share is expected to grow.

The drive to total automation is an economics of production and a market demand for vegan alternatives. As the market for vegan supplements and pharmaceuticals grows, manufacturers that can consistently and at high speed process plant-based shell materials are gaining competitive advantage. Machine manufacturers that offer dual-capability lines with in-line weight checking, vision inspection and automated packaging integration are well-positioned to capture premium demand.

Regional Outlook Across Key Markets

• India is leading with 7% growth with growth driven by expanding domestic demand, infrastructure investment and policy-driven adoption.
• North America is mixed with the U.S. at 5.4% representing a mature market with well-established replacement cycles and technology upgrade activity.
• European demand is steady, with Germany at 4.2% driven by regulatory compliance, process modernisation and quality-driven procurement.

CAGR Table

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research.

Market Outlook for Softgel Encapsulation Machines in India

The India softgel encapsulation machine market is projected to grow at a CAGR of 7.0% through 2036. Demand is shaped by pharmaceutical manufacturing expansion, supplement production growth, and contract manufacturing investment.

• Pharmaceutical manufacturing expansion drives machine procurement.
• Supplement production growth generates capacity investment.
• Contract manufacturing creates multi-product line demand.

China Softgel Encapsulation Machine Demand Trends

The China softgel encapsulation machine market is projected to grow at a CAGR of 6.0% through 2036. Demand is supported by pharmaceutical production, domestic supplement manufacturing, and equipment export capability.

• Pharmaceutical production drives encapsulation equipment demand.
• Domestic supplement manufacturing generates capacity investment.
• Equipment manufacturing supports competitive pricing and export.

United States Softgel Encapsulation Machine Market Outlook

The U.S. softgel encapsulation machine market is projected to grow at a CAGR of 5.4% through 2036. Demand is supported by pharmaceutical manufacturing, supplement industry growth, and contract manufacturing expansion.

• Pharmaceutical manufacturing sustains machine procurement.
• Supplement industry growth drives capacity expansion.
• Contract manufacturing creates high-speed line demand.

South Korea Softgel Encapsulation Machine Demand Analysis

The South Korea softgel encapsulation machine market is projected to grow at a CAGR of 4.5% through 2036. Demand is supported by pharmaceutical production, health supplement manufacturing, and beauty nutrition expansion.

• Pharmaceutical production drives core machine demand.
• Health supplement manufacturing generates capacity investment.
• Beauty nutrition expansion supports softgel production growth.

Germany Softgel Encapsulation Machine Growth Assessment

The Germany softgel encapsulation machine market is projected to grow at a CAGR of 4.2% through 2036. Demand is supported by pharmaceutical manufacturing standards, supplement production, and equipment engineering export.

• Pharmaceutical standards drive high-specification machine demand.
• Supplement production generates encapsulation capacity investment.
• Equipment export supports domestic manufacturing activity.

Italy Softgel Encapsulation Machine Market Demand Analysis

The Italy softgel encapsulation machine market is projected to grow at a CAGR of 4.0% through 2036. Demand is supported by pharmaceutical manufacturing, nutraceutical production, and packaging machinery manufacturing tradition.

• Pharmaceutical manufacturing drives machine procurement.
• Nutraceutical production generates capacity expansion demand.
• Packaging machinery tradition supports domestic equipment manufacturing.

Japan Softgel Encapsulation Machine Growth Outlook

The Japan softgel encapsulation machine market is projected to grow at a CAGR of 3.8% through 2036. Demand is shaped by pharmaceutical precision requirements, health supplement production, and high-quality machine specification.

• Pharmaceutical precision drives high-specification machine demand.
• Health supplement production sustains encapsulation capacity.
• Quality specification supports premium equipment adoption.

Competitive Benchmarking and Company Positioning

Softgel Encapsulation Machine Market Analysis By Company

• IMA Group, Bosch Packaging, Harro Hofliger, and ACG hold strong positions in the global softgel encapsulation machine market through comprehensive pharmaceutical packaging portfolios, validated machine platforms, and established pharmaceutical manufacturer relationships.
• Romaco, Fette Compacting, Marchesini, and SaintyCo compete through specific encapsulation technology expertise, regional distribution strength, and targeted positions in supplement, contract manufacturing, and emerging market segments.
• Competition is increasingly defined by automation level, plant-based capsule capability, and integrated quality inspection, with manufacturers offering high-speed lines with dual gelatin and vegan shell processing gaining specification advantage.

The competitive landscape is moderately concentrated among global pharmaceutical packaging equipment manufacturers. IMA Group, Bosch Packaging, and Harro Hofliger compete through comprehensive machine portfolios, pharmaceutical validation capability, and established global distribution.

ACG, Romaco, Fette Compacting, Marchesini, and SaintyCo maintain positions through encapsulation specialization, regional manufacturing, and targeted market focus.

GEA, Ompi, EncapsulationTech, ACG Capsules, Nipro, Lujida, and MachineWorks add competition across specific machine configurations, price points, and emerging market supply.

Strategic priorities include developing plant-based encapsulation capability, expanding high-speed automated line portfolios, strengthening pharmaceutical validation support, and growing positions in high-growth pharmaceutical manufacturing markets.

Key Companies in the Softgel Encapsulation Machine Market

• IMA Group, Bosch Packaging, Harro Höfliger, ACG are among the leading players in the softgel encapsulation machine market globally, supported by strong brand visibility, broad product portfolios, and established positions across core end-use segments.
• Romaco, Fette Compacting, Marchesini, SaintyCo hold established positions across specific application verticals, geographic markets, and technology tiers, supported by product quality, distribution penetration, and category experience.
• GEA, Ompi, EncapsulationTech, ACG Capsules, Nipro, Lujida, MachineWorks continue to compete through focused product offerings, price-point coverage, and niche strength in specific applications or regional markets.

Recent Industry Developments

• IMA Group – Technology Launch / High-Speed Automated Encapsulation Line (2025)
  • IMA introduced a high-speed softgel encapsulation line with integrated weight checking, vision inspection, and automated reject capability for pharmaceutical production.
• ACG – Product Launch / Plant-Based Softgel Machine (2025)
  • ACG launched an encapsulation machine optimized for plant-based and vegan softgel production, supporting the growing demand for non-gelatin capsule manufacturing
• SaintyCo – Product Line Expansion / Semi-Automatic Encapsulation System (February 2026)
  • SaintyCo expanded its softgel equipment portfolio with a laboratory-scale R&D softgel encapsulation system targeting contract manufacturers and R&D facilities requiring flexible, lower-throughput production.

Leading Companies Shaping the Softgel Encapsulation Machine Market

• IMA Group
• Bosch Packaging
• Harro Höfliger
• ACG
• Romaco
• Fette Compacting
• Marchesini
• SaintyCo
• GEA
• Ompi
• EncapsulationTech
• ACG Capsules
• Nipro
• Lujida
• MachineWorks

Sources and Research References

• IMA Group. High-speed automated encapsulation line and pharmaceutical packaging updates.
• ACG. Plant-based softgel machine and capsule manufacturing technology updates.
• SaintyCo. Semi-automatic encapsulation system and production equipment expansion.
• Pharmaceutical manufacturing statistics, dietary supplement production data, contract manufacturing reports, and packaging equipment market publications.
• Primary interviews with encapsulation machine manufacturers, pharmaceutical producers, supplement companies, contract manufacturers, and packaging engineers.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

• What is the current and future size of the Softgel Encapsulation Machine Market?
• How fast is the market expected to grow between 2026 and 2036?
• Which product type is likely to lead the market by 2026?
• Which application segment accounts for the highest demand by 2026?
• What factors are driving demand for softgel encapsulation machines globally?
• How is the shift toward plant-based softgels influencing the market?
• Why are India and China the fastest-growing markets?
• How is contract manufacturing driving machine procurement?
• Which countries are projected to show the fastest growth through 2036?
• Who are the key companies active in this market?
• How does Fact.MR estimate and validate the market forecast?

Softgel Encapsulation Machine Market Definition

The softgel encapsulation machine market covers pharmaceutical manufacturing equipment for soft gelatin capsule production across rotary die, plate-type, die roller, fully automatic, and semi-automatic configurations.

Softgel Encapsulation Machine Market Inclusions

• The scope covers global and regional market size and forecasts for 2026 to 2036 across product type, application, end use, technology, formulation, and distribution channel.
• It includes regional demand analysis based on pharmaceutical production, supplement manufacturing, contract manufacturing, and cosmetic softgel adoption.
• The report covers technology trends, market drivers and constraints, and the competitive landscape, including machine capability, validation support, and client portfolios.
• It includes pricing and cost analysis across semi-automatic, fully automatic, and high-speed encapsulation machine categories.

Softgel Encapsulation Machine Market Exclusions

• The scope excludes hard capsule filling machines, tablet presses, and other solid dosage form equipment.
• It excludes gelatin and shell material supply, capsule raw materials, and fill formulation ingredients.
• The report excludes packaging equipment downstream of encapsulation including blister packing and bottling machinery.
• It also excludes laboratory-scale encapsulation devices without commercial production capability.

Softgel Encapsulation Machine Market Research Methodology

• The methodology combines secondary research, primary interviews, and forecast modelling.
• It draws on 100+ secondary sources and benchmarks 50+ company product portfolios.
• Market sizing covers 30+ countries through a demand-side model, supported by top-down validation.
• Key inputs include application demand trends, regulatory activity, end-use adoption rates, pricing analysis, and distribution penetration.
• The model cross-checks demand with shipments, pricing trends, channel mix, and product launches.
• Primary validation includes 25+ interviews across manufacturers, distributors, end users, and industry participants.
• Final estimates go through trade-flow checks, sales-pattern review, and sensitivity testing.